Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transfusion Thresholds in Pancreatectomy
NCT05841706Phase 1Terminated
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Aug 2023
- Primary completion
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of red blood cells in anemia (2 arms), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoint: Rate of Protocol adherence. Started Aug 2023; status: terminated.
02
Drugs
red blood cells
03
Conditions
anemia
Beyond the preview
Go deeper on NCT05841706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05841706.